Latest p/e ratio
Theravance Biopharma P/E ratio
Direct answer
Theravance Biopharma's p/e ratio is 16.38x.
The verified market snapshot reports 16.38x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 16, 2026.
Get free Theravance Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- P/E ratio
- 16.38x
Explore related company data
View Theravance Biopharma's market capitalizationView Theravance Biopharma's price-to-book ratioView Theravance Biopharma's return on equityView Theravance Biopharma's 52-week price rangeView Theravance Biopharma's revenue growthView Theravance Biopharma's profit marginView Theravance Biopharma's debt-to-equity ratioView all Theravance Biopharma key metricsReturn to Theravance Biopharma profile